Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05269212 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Return to Work for Persistent Spinal Pain Syndrome Type II Patients

Study acronym: OPERA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Aug 2025 to Aug 2027v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2022 to May 10, 2022
    • Site details revised at 5 of 5 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A multicenter randomized controlled trial will be conducted to evaluate whether the ability to work in Persistent Spinal Pain Syndrome Type II (PSPS-T2) patients after SCS implantation is different after a personalized biopsychosocial rehabilitation program specifically targeting return to work (RTW) compared with usual care.
Trial Details
NCT Number NCT05269212
Lead Sponsor Moens Maarten
Collaborators: Vrije Universiteit Brussel, University Ghent, KU Leuven
Conditions
(from sponsor)		 Failed Back Surgery Syndrome, Spinal Cord Stimulation
Related terms Failed Back Surgery Syndrome
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov